These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 10429716)
1. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Orel SG; Weinstein SP; Schnall MD; Reynolds CA; Schuchter LM; Fraker DL; Solin LJ Radiology; 1999 Aug; 212(2):543-9. PubMed ID: 10429716 [TBL] [Abstract][Full Text] [Related]
2. MR imaging of the breast in patients with occult primary breast carcinoma. Morris EA; Schwartz LH; Dershaw DD; van Zee KJ; Abramson AF; Liberman L Radiology; 1997 Nov; 205(2):437-40. PubMed ID: 9356625 [TBL] [Abstract][Full Text] [Related]
3. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Lee SG; Orel SG; Woo IJ; Cruz-Jove E; Putt ME; Solin LJ; Czerniecki BJ; Schnall MD Radiology; 2003 Mar; 226(3):773-8. PubMed ID: 12601182 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Yeung DK; Yang WT; Tse GM Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004 [TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Fischer U; Kopka L; Grabbe E Radiology; 1999 Dec; 213(3):881-8. PubMed ID: 10580970 [TBL] [Abstract][Full Text] [Related]
6. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Ko EY; Han BK; Shin JH; Kang SS Korean J Radiol; 2007; 8(5):382-9. PubMed ID: 17923780 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
8. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Orel SG; Schnall MD; Powell CM; Hochman MG; Solin LJ; Fowble BL; Torosian MH; Rosato EF Radiology; 1995 Jul; 196(1):115-22. PubMed ID: 7784554 [TBL] [Abstract][Full Text] [Related]
9. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for axillary staging in patients with breast cancer. Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713 [TBL] [Abstract][Full Text] [Related]
11. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910 [TBL] [Abstract][Full Text] [Related]
12. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796 [TBL] [Abstract][Full Text] [Related]
13. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Scaranelo AM; Eiada R; Jacks LM; Kulkarni SR; Crystal P Radiology; 2012 Feb; 262(2):425-34. PubMed ID: 22143924 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922 [TBL] [Abstract][Full Text] [Related]
15. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803 [TBL] [Abstract][Full Text] [Related]
16. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383 [TBL] [Abstract][Full Text] [Related]
18. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914 [TBL] [Abstract][Full Text] [Related]
19. Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: the role of breast magnetic resonance imaging for staging. Chen C; Orel SG; Schnall MD; Harris E; Solin LJ Clin Breast Cancer; 2002 Aug; 3(3):219-22. PubMed ID: 12196282 [TBL] [Abstract][Full Text] [Related]
20. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma. Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]